<i>CYP2D6</i> Genotype and Pharmacovigilance Impact on Autism Spectrum Disorder: A Naturalistic Study with Extreme Phenotype Analysis

• Päätekijät: Pura Ballester (Tekijä), Cristina Espadas (Tekijä), Susana Almenara (Tekijä), Jordi Barrachina (Tekijä), Javier Muriel (Tekijä), Enrique Ramos (Tekijä), Natalia Toral (Tekijä), César Belda (Tekijä), Ana M. Peiró (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: MDPI AG, 2023-07-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

The long-term use of psychopharmacology medications in autism spectrum disorder (ASD) hitherto remains controversial due to a lack of evidence about safety and tolerability. In this regard, genotyping the metabolizing enzyme cytochrome P450 <i>(CYP) 2D6</i>, especially its extreme phenot...